Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children
Open Access
- 6 October 2015
- journal article
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 25 (5) , e3313
Abstract
Background: Leukotriene receptor antagonists (LTRAs) are drugs which have been widely used more than ten years. As the use of LTRAs increases, our knowledge with respect to their side effects increases as well. Objectives: The objective of our study was to evaluat the observed side effects of LTRAs used in patients with astma. Patients and Methods: 1024 patients treated only with LTRAs owing to asthma or early wheezing were included in the study for a five-year period. The observed side effects of LTRAs in these patients were retrospectively investigated. The side effects were divided into two parts as psychiatric and non-psychiatric. Results: Among the 1024 cases included in the study, 67.5% of the patients out of 41 with side effects were male, 32.5% were female and the average age was 6.5 years. The rate of patients with asthma was 63.41% and 36.58% of the patients had early wheezing. It was determined that sex, age and diagnosis (early wheezing or asthma) of the patients were ineffective in the emergence of side effects. The average period for the emergence of side effects was the first month. It was observed that hyperactivity was the most frequently observed psychiatric side effect and that abdominal pain was the non-psychiatric side effect. Conclusions: The side effects of LTRAs were common in children. Therefore, patients must be informed at the beginning of the treatment and they must be evaluated at certain intervals. Keywords: Asthma; Children; Leukotriene Receptor Antagonists; Side Effect; WheezingKeywords
This publication has 30 references indexed in Scilit:
- Antileukotriene Agents for the Treatment of Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Update on leukotriene receptor antagonists in preschool children wheezing disordersItalian Journal of Pediatrics, 2012
- Psychiatric adverse drug reactions reported during a 10‐year period in the Swedish pediatric populationPharmacoepidemiology and Drug Safety, 2011
- Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensionsPediatric Pulmonology, 2009
- Review of recent results of montelukast use as a monotherapy in children with mild asthmaClinical Therapeutics, 2008
- Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in miceActa Pharmacologica Sinica, 2007
- Churg–Strauss syndrome associated with leukotriene receptor antagonists (LTRA)Clinical Rheumatology, 2007
- Cysteinyl leukotrienes: multi‐functional mediators in allergic rhinitisClinical & Experimental Allergy, 2006
- Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trialThe Lancet, 2001
- Leukotriene Modifiers and Churg-Strauss SyndromeDrug Safety, 1999